Support your patient through their vaginal atrophy journey this winter
Prescribing and Adverse event reporting information for BlisselⓇ can be found here.
Understanding their condition may be a priority for women, but they may prefer their doctor or nurse to start the discussion.1
Diagnosing and treating vaginal atrophy early can allow you to impact women’s quality of life by interrupting the progressive changes that the condition can bring.2-4
The diagnosis of vaginal atrophy is not always straightforward
The diagnosis of vaginal atrophy can be made more difficult by the various ways in which it can present, including vaginal dryness, dysuria, itching, burning, and pain during sex.5
Women may be hesitant to discuss the symptoms of vaginal atrophy.6
Whilst every patient is unique, common motivations can be embarrassment, thinking that it is inappropriate to discuss the subject, or feeling that there is no treatment available.6
Using Blissel® to treat vaginal atrophy
Blissel® is an ultra low dose estriol vaginal gel containing 50 micrograms per dose (1 gram) of estriol, indicated for treating the symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women.7,8
The treatment has been shown to be well tolerated and effective for postmenopausal vaginal atrophy.7 Blissel® can give your patients a rapid improvement in their symptoms from the very first days of treatment.9
Prescribing and Adverse event reporting information for BlisselⓇ can be found here.
Understanding their condition may be a priority for women, but they may prefer their doctor or nurse to start the discussion.1
Diagnosing and treating vaginal atrophy early can allow you to impact women’s quality of life by interrupting the progressive changes that the condition can bring.2-4
The diagnosis of vaginal atrophy is not always straightforward
The diagnosis of vaginal atrophy can be made more difficult by the various ways in which it can present, including vaginal dryness, dysuria, itching, burning, and pain during sex.5
Women may be hesitant to discuss the symptoms of vaginal atrophy.6
Whilst every patient is unique, common motivations can be embarrassment, thinking that it is inappropriate to discuss the subject, or feeling that there is no treatment available.6
Using Blissel® to treat vaginal atrophy
Blissel® is an ultra low dose estriol vaginal gel containing 50 micrograms per dose (1 gram) of estriol, indicated for treating the symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women.7,8
The treatment has been shown to be well tolerated and effective for postmenopausal vaginal atrophy.7 Blissel® can give your patients a rapid improvement in their symptoms from the very first days of treatment.9
My Blissel® Time to talk
Video Library
A library of discussions led by national experts Dr Anne Connolly, Dr Diana Mansour and Nurse Specialist Consultant Nikki Noble.
The videos cover a range of very useful, relevant and important topics including, the signs and symptoms of VA, how to make the diagnosis and the impact of vaginal atrophy on a patients quality of life.
Prescribe Blissel® by brand for your patients.
Blissel® is the first and only prescribable estriol containing gel for the treatment of vaginal atrophy7,8
Patients have difficulty discussing their condition
For reasons that are understandable, women may hesitate when discussing vaginal symptoms.6
Whilst there can be many motivations, they can commonly include embarrassment, feeling the discussion is inappropriate, or that nothing can be done.6
Blissel®treats the bothersome symptoms of vaginal atrophy
Blissel® is an ultra low dose estriol vaginal gel containing 50 micrograms per dose (1 gram) of estriol, indicated for treating the symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women.7,8
Upcoming Webinars 2025
4th Feb
7pm to
9pm
Balancing Act: Hormone replacement therapy HRT in Genitourinary health with Dr Diana Mansour.
Looking for more information on understanding Menopause and Genitourinary symptoms?
For more information please click below.
How BlisselⓇ
Works
Efficacy
Dosing
Ultra low dose estriol vaginal gel7,8
Prescribing and Adverse event reporting information for BlisselⓇ can be found here.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Consilient Health (UK) Ltd, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com
- Krychman M, et al. J Sex Med 2017;14:425-433.
- Moral E, et al. Menopause. 2018;25(12):1418-23.
- Cagnacci A, et al. Climacteric. 2019;22(1):85-89.
- NAMS position statement. Menopause. 2020;27(9):976-92.
- Palmaa F, et al. Maturitas. 2018;108:18–23.
- Kagan R, et al. Drugs Aging. 2019;36:897–908.
- Cano A, et al. Menopause. 2012;19(10):1130-9.
- Blissel 50 micrograms/g vaginal gel. Summary of product characteristics.
- Lázaro-Carrasco de la Fuente J, et al. J Menopausal Med. 2022;28(2):60-69.
Date of preparation: Dec 2024 | UK-BLS-586(2)